
Prof. Jason Yam is Professor in the Department of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong. He serves as Head of Pediatric Ophthalmology and Strabismus at Hong Kong Eye Hospital, Head of Ophthalmology at Hong Kong Children’s Hospital, Editor-in-Chief of the College of Ophthalmologists of Hong Kong, and President of the Hong Kong Ophthalmological Society.
He established the role of low-concentration atropine in myopia control and prevention, reshaping the treatment paradigm. He has published more than 250 SCI-indexed articles in journals including JAMA, Lancet Global Health, Ophthalmology, and JAMA Network Open. His work on low-concentration atropine for myopia control and prevention was named one of “China’s Important Medical Advancements in 2023”.
He is a member of the Hong Kong Young Academy of Sciences and a Chair of Academia Ophthalmologica Internationalis. His honours include the 2024 National Science Fund for Distinguished Young Scholars, the 2024 APAO De Ocampo Lecture Award, Hong Kong’s Ten Outstanding Young Persons Award in 2019, and the 2022 Josh Wallman Memorial Lecture. Since 2022, he has ranked among the world’s top 2% of scientists in ophthalmology and was named one of the Asia-Pacific region’s top 100 ophthalmologists since 2023.